Analyst picks & changes

Immunex Corp.

(IMNX)

Stuart Weisbrod of Merrill Lynch lowered his intermediate-term rating to "neutral" from "above average" after

Read the full 186 word article

How to gain access

Continue reading with a
two-week free trial.